Directorate Change
December 02 2002 - 9:11AM
UK Regulatory
RNS Number:5455E
Cambridge Antibody Tech Group PLC
02 December 2002
Following an announcement on 18 November 2002, the Company is pleased to confirm
that Ake Bu Tage Stavling has today been appointed as a Non Executive Director.
Mr Stavling currently serves as a director of AstraZeneca PLC and has not served
as a director of any other quoted company in the past five years. The Company is
pleased to report that no disclosure requirement arises pursuant to rule
16.4 (b) of the Listing Rules.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOABUBDDCGGGGDD
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Oct 2023 to Oct 2024